A revolutionary drug can drastically slash the risk of women with the ' gene' dying from breast cancer.Scientists studied nearly 2,000 women with early-stage cancer, all of whom had the BRCA1 and BRCA2 mutations. Half were given olaparib tablets to take twice a day for a year, while the others were given a placebo.
Load More
Load More